Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
QuintilesIMS
AstraZeneca
Chinese Patent Office
Healthtrust
McKesson
Cerilliant
UBS
Fuji

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 085441

« Back to Dashboard

NDA 085441 describes BUTALBITAL, ASPIRIN AND CAFFEINE, which is a drug marketed by Nostrum Labs Inc, Watson Labs, Actavis Elizabeth, Fosun Pharma, Halsey, Hikma Intl Pharms, Ivax Pharms, PII, Puracap Pharm, and Quantum Pharmics, and is included in eleven NDAs. It is available from seven suppliers. Additional details are available on the BUTALBITAL, ASPIRIN AND CAFFEINE profile page.

The generic ingredient in BUTALBITAL, ASPIRIN AND CAFFEINE is aspirin; butalbital; caffeine. There are twenty-one drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the aspirin; butalbital; caffeine profile page.
Summary for 085441
Tradename:BUTALBITAL, ASPIRIN AND CAFFEINE
Applicant:Ivax Pharms
Ingredient:aspirin; butalbital; caffeine
Patents:0
Formulation / Manufacturing:see details

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength325MG;50MG;40MG
Approval Date:Oct 31, 1984TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Daiichi Sankyo
QuintilesIMS
McKesson
Argus Health
Citi
Dow
Baxter
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.